On November 24, the CNAO (Centro Nazionale di Adroterapia Oncologica) hadrontherapy centre in Pavia, Italy, will organise a special event to celebrate twenty years of CNAO.
As the response to the pandemic evolves and people step back into the office, it is necessary to monitor continuously the risk of disease transmission and be prepared to make quick, evidence-based decisions to ensure that everyone can work safely.
The CERN-developed COVID Airborne Risk Assessment tool (CARA) is helping researchers from the University of Geneva assess the effectiveness of different measures to limit SARS-CoV-2 aerosol transmission in schools.
Frontier instruments like the LHC and its detectors not only push back the boundaries of our knowledge, but also catalyse innovative technology for medical applications, writes Manuela Cirilli.
